43 | | - | requiring health benefit plans to adhere to certain |
---|
44 | | - | requirements; requiring certain drugs to meet federal |
---|
45 | | - | requirements; prohibiting plans from imposing certain |
---|
46 | | - | requirements or payments; establishing certain drug |
---|
47 | | - | administration requirements; creating a penalty; |
---|
48 | | - | providing for codification; and declaring an |
---|
49 | | - | emergency. |
---|
| 66 | + | prohibiting certain drug plans from refusing certain |
---|
| 67 | + | dispensing of physician-administered or injectable |
---|
| 68 | + | drugs under certain circumstances ; requiring certain |
---|
| 69 | + | drugs meet certain federal requirements; prohibiting |
---|
| 70 | + | patients from payment of certain fees beyond cost- |
---|
| 71 | + | sharing obligation; establishing penalties; providing |
---|
| 72 | + | immunity from liability to c ertain providers; |
---|
| 73 | + | providing for codification; and provi ding an |
---|
| 74 | + | effective date. |
---|
59 | | - | 1. “Health benefit plan” means a health benefit plan as defined |
---|
60 | | - | pursuant to Section 6060.4 of Title 36 of the Oklah oma Statutes; |
---|
61 | | - | 2. “Pharmacy benefits manager” means a person that performs |
---|
62 | | - | pharmacy benefits management and any other person acting for such |
---|
63 | | - | person under a contractual or employment relationship in the |
---|
64 | | - | performance of pharmacy benefits management for a mana ged-care |
---|
| 84 | + | 1. “Health care provider” means a provider as defined pursuant |
---|
| 85 | + | to Section 6571 of Title 36 of the Oklahoma Statu tes; |
---|
| 86 | + | 2. “Pharmacy benefits manager” means a manager as defined |
---|
| 87 | + | pursuant to Section 6960 of Title 36 of the Oklahoma Statutes; and |
---|
91 | | - | company, not-for-profit hospital, medical serv ices organization, |
---|
92 | | - | insurance company, third-party payor, or a health program |
---|
93 | | - | administered by a state agency ; and |
---|
94 | | - | 3. “White bagged drugs” means the distribution of physician - |
---|
95 | | - | administered medication from a pharmacy, typically a specialty |
---|
96 | | - | pharmacy, to the physician’s office, hospital, or clinic for |
---|
97 | | - | administration. |
---|
98 | | - | B. All health benefit plans and pharmacy benefits managers in |
---|
99 | | - | this state shall not refuse to authorize, approv e, or pay a |
---|
100 | | - | participating provider for providing covered physician-administered |
---|
101 | | - | drugs to covered persons. |
---|
| 139 | + | 3. “White bagged drugs” means a patient-specific medication |
---|
| 140 | + | distributed from a pharmacy, typically a third-party specialty |
---|
| 141 | + | pharmacy, to a health care provider for administration. |
---|
| 142 | + | B. In the event that a health care provider dispenses or |
---|
| 143 | + | administers a white bag ged drug to a patient, that patient’s |
---|
| 144 | + | pharmaceutical drug plan or the pharmac y benefits manager of the |
---|
| 145 | + | drug plan shall not refuse to approve, authorize, or pay the third- |
---|
| 146 | + | party specialty pharmacy for the drug solely because the drug is a |
---|
| 147 | + | white bagged drug. |
---|
104 | | - | Chain Security Act as amended. |
---|
105 | | - | D. A health benefit plan or a pharmacy benefits manager of a |
---|
106 | | - | plan shall not require a covered patient to self-administer an |
---|
107 | | - | injectable drug against a health care provider’s recommendation in |
---|
108 | | - | accordance with the manufacturer ’s approved guidelines . |
---|
109 | | - | E. Health benefit plans shall not require a covered patient to |
---|
110 | | - | pay additional fees for white bagged drugs beyond cost-sharing |
---|
111 | | - | obligations as outlined in the individual ’s plan. |
---|
112 | | - | F. Providers and health care facilities shall be permitted to |
---|
113 | | - | dispense and administer a covered physician-administered drug based |
---|
114 | | - | on a patient’s best interest, provided that the health care facility |
---|
| 150 | + | Chain Security Act as amended. The State Board of Pharmacy may |
---|
| 151 | + | promulgate rules related to supply, storage, and transaction history |
---|
| 152 | + | to ensure that white bagged drugs are in compliance with federal |
---|
| 153 | + | law. |
---|
| 154 | + | D. A pharmaceutical drug plan or a pharmacy benefits manager of |
---|
| 155 | + | a plan shall not require a covered patient to self-administer an |
---|
| 156 | + | injectable white bagged drug against a health care provider’s |
---|
| 157 | + | recommendation. |
---|
| 158 | + | E. A pharmaceutical drug plan or a pharmacy benefits manager of |
---|
| 159 | + | a plan shall not require a covered patient to pay additional fees |
---|
| 160 | + | for white bagged drugs beyond cost-sharing obligations as outlined |
---|
| 161 | + | in the individual’s plan. |
---|
141 | | - | or provider that administers the drug shall agree to the terms and |
---|
142 | | - | conditions of network participation and accept, as payment in full, |
---|
143 | | - | reimbursement for the drug at the health insurer’s or pharmacy |
---|
144 | | - | benefits manager’s negotiated contracted rate . The health care |
---|
145 | | - | facility or provider is prohibited from billing or collecting from |
---|
146 | | - | the patient any amount in excess of or in addition to the patient’s |
---|
147 | | - | cost sharing obligations as outlined in the individual’s plan. |
---|
148 | | - | G. Any payor in violation of this act shall be fined a minimum |
---|
149 | | - | of Five Thousand Dollars ($5,000.00) per violation, but not more |
---|
150 | | - | than Ten Thousand Dollar s ($10,000.00) per violati on. Fines related |
---|
151 | | - | to this section shall not be used when calculating pay ors, plans, or |
---|
152 | | - | members loss ratios and lo sses incurred pursuant to this subsection |
---|
153 | | - | shall not be passed on to the consumer in future rate increases. |
---|
154 | | - | H. A health care provider or facility shall be immune from |
---|
155 | | - | civil liability for any lo ss or harm to a person due to his or her |
---|
156 | | - | health insurance plan utilizin g white bagged drugs caused by an act |
---|
157 | | - | or omission by the facility or provider that occurs during the |
---|
158 | | - | process outlined in this act if the act or omission was not the |
---|
159 | | - | result of gross negligenc e or willful or wanton misconduct o f the |
---|
160 | | - | health care facility o r health care provider rendering the health |
---|
161 | | - | care services. |
---|
162 | | - | SECTION 2. It being immediately necessary for the pr eservation |
---|
163 | | - | of the public peace, health or safety, an emergency is hereby |
---|
| 213 | + | F. Any pharmaceutical drug plan or pharmacy benefits manager in |
---|
| 214 | + | violation of this act shall be fined a minimum of Five Thousan d |
---|
| 215 | + | Dollars ($5,000.00) per violation, but not more than Ten Thousand |
---|
| 216 | + | Dollars ($10,000.00) per violati on. Fines related to this section |
---|
| 217 | + | shall not be used when calculating pay ers, plans, or members loss |
---|
| 218 | + | ratios and losses incurred pursuant to this subsection shall not be |
---|
| 219 | + | passed on to the insured in future rate increases. |
---|
| 220 | + | G. A health care provider shall be immune from civil liability |
---|
| 221 | + | for any loss or harm to a person due to his or her health insurance |
---|
| 222 | + | plan utilizing white bagged drugs caused by an act or omission by |
---|
| 223 | + | the facility or provider that occurs during the process outlined in |
---|
| 224 | + | this act if the act or omission was not the result of gross |
---|
| 225 | + | negligence or willful or wanton misconduct o f the health care |
---|
| 226 | + | facility or health care provider rendering the health care servic es. |
---|
| 227 | + | SECTION 2. This act shall become effective November 1 , 2023. |
---|